RecruitingNCT03148743
FMT in Gut aGVHD Treated
Department of Hematology of First Affiliated Hospital of Soochow University
Sponsor
The First Affiliated Hospital of Soochow University
Enrollment
50 participants
Start Date
May 16, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
With the stem cell transplanting increasing, patients which effected with gut GVHD were also increased. To evaluation the safety and efficacy of FMT for gut GVHD,patients with gut GVHD were recruited.
Eligibility
Min Age: 10 YearsMax Age: 60 Years
Inclusion Criteria1
- gut GVHD
Exclusion Criteria1
- Age>60; or Age<10
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALFecal microbiota
fecal microbiota transplantation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03148743
Related Trials
Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
NCT075350081 location
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
NCT075726691 location
MAGIC Ruxolitinib for aGVHD
NCT0693656614 locations
A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD.
NCT070706741 location
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
NCT052360622 locations